Position in NAGE
as of Mar 31, 2026
· filed Jul 17, 2026
Position Value
$458,313
-$2,011,134 QoQ
Shares Held
103,926
-73.2% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 0%
Shared 38%
None 62%
Common Shares in NAGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AMERIPRISE FINANCIAL INC holds $4,254,627,646 across 191 Biotechnology names. NAGE ranks #157 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,633,481 | $1,175,954,602 | |
| 2 | INSM |
INSMED Inc
|
3,057,718 | $499,998,043 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,608,476 | $304,082,386 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
319,677 | $246,995,233 | |
| 5 | ARGX |
Argenx SE
|
215,910 | $157,668,275 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,579,793 | $153,634,868 | |
| 7 | ASND |
Ascendis Pharma A/S
|
476,466 | $108,982,067 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,248,521 | $92,715,166 |
All Filings in NAGE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $458,313 | 103,926 | Shares | Defined | 2026-07-17 | |
| 2025-12-31 | $2,469,447 | 388,278 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,576,776 | 383,363 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,232,292 | 224,309 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,043,454 | 296,153 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,752,235 | 329,988 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $385,399 | 105,589 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $54,845 | 20,090 | Shares | Defined | 2024-08-14 | |
| 2022-12-31 | $29,428 | 17,517 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $43,522 | 35,384 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $76,292 | 45,684 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $124,718 | 50,699 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $190,306 | 50,884 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $401,493 | 64,034 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $635,171 | 64,419 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $262,864 | 28,144 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $67,123 | 13,984 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $56,075 | 13,984 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $64,186 | 13,984 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $45,603 | 13,989 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||